Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape.

The aim of the study was to investigate trends of FT for in-patient treatment of renal RCC in the USA and Germany.

We analyzed the SEER database for the USA and the nationwide German hospital billing database each from 2006 to 2019 for a RCC diagnosis in combination with FT, radical nephrectomy, and partial nephrectomy. FT was defined as radiofrequency ablation (RFA) or cryotherapy. Linear regression analysis was performed to detect changes over time.

For the USA, we included 7,318 FT cases. The share of FT increased from 2.4% in 2006 to 6.4% in 2019 (p < 0.001). For Germany, we identified 2,920 FT cases. The share of FT increased from 0.7% in 2006 to 2.0% in 2019 (p < 0.001). The number of RFAs in the USA steadily increased by 227% from a total of 93 in 2006 to 304 in 2019 while the number of cryotherapies in the USA steadily increased by 289% from a total of 127 in 2006 to 494 in 2019 (p < 0.001). The number of RFAs in Germany increased by 344% from a total of 59 in 2006 to 262 in 2019 (p < 0.001) while the number of cryotherapies steadily increased by 43% from a total of 54 in 2006 to 77 in 2019 (p < 0.001). In Germany, RFA is significantly more performed than cryotherapy while in the USA cryotherapy is more frequently applied.

We observed a constant increase of FT in the USA and Germany for RCC in-patient treatment with a higher share in the USA.

Urologia internationalis. 2023 Jan 26 [Epub ahead of print]

Luka Flegar, Smita George Thoduka, Andreas H Mahnken, Jens Figiel, Hendrik Heers, Cem Aksoy, Nicole Eisenmenger, Christer Groeben, Johannes Huber, Aristeidis Zacharis

Department of Urology, Philipps-University Marburg, Marburg, Germany., Department of Diagnostic and Interventional Radiology, Philipps-University Marburg, Marburg, Germany., Reimbursement Institute, Hürth, Germany.